Capio AB
Investment Company
| Name | Capio AB |
|---|---|
| Sektor | Gesundheitswesen |
| Land | Schweden |
| Erstes Inv. |
2006 |
| Geschäftsfokus | Operator of hospitals and diagnostics centres |
| Kontakt |
Capio hält nach Ablauf der Hauptangebotsfrist 98.13% der Stimmrechte von Unilabs
Capio teilt heute mit, dass das Unternehmen und die in gemeinsamer Absprache handelnden Gesellschaften und Personen nach Ablauf der Hauptangebotsfrist am 5. November 2007 98.13% der Stimmen aller ausgegebenen Unilabs-Aktien halten.
Weiter >>Capio announces closing of purchase of Unilabs’ majority shareholders’ stake
Capio today announced that it has closed its purchase of the entire stake of registered and bearer shares and options of Unilabs from its majority shareholders.
Weiter >>Opica holds 99.3% of the shares and votes in Capio
Opica holds 99.3% of the shares and votes in Capio. Capio has been delisted from the Stockholm Stock Exchange. Compulsory acquisition has been initiated.
Weiter >>Presse
Apax Partners completes acquisition of TriZetto Group
The TriZetto Group, Inc. and Apax Partners announced today the closing of the merger pursuant to which funds advised by Apax Partners, together with minority investors BlueCross BlueShield of Tennessee and The Regence Group, acquired all of TriZetto’s common stock for $22 cash per share.
TriZetto agrees to be acquired by Apax Partners for $22 per share
The TriZetto Group, Inc. announced today that it has entered into a definitive agreement to be acquired and taken private by funds advised by Apax Partners.
Apax Partners Acquires Qualitest Pharmaceuticals and Vintage Pharmaceuticals
Funds advised by Apax Partners have agreed to acquire Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals based in Huntsville, Alabama, USA.